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Acetate and bicarbonate hemodialysis in patients with and without au-
tonomic dysfunction. To test the contribution of bicarbonate (Bi) to he-
modynamic stability during hemodialysis (ND), we compared the ef-
fects of ultrafiltration dialysis with bicarbonate and with acetate under
conditions of high-sodium (141 mEq/liter) and low-sodium (130
mEq/liter) dialysate concentrations in 12 stable HD patients. Group 1
was patients (N = 5) who had normal findings on autonomic testing;
group 2, patients (N = 7) who had abnormal findings on autonomic
testing. All patients and staff were unaware of which dialysate was
being used. During the high-sodium dialysate studies, changes in mean
blood pressure (MBP), cardiac output (CO), and orthostatic tolerance
to standing after HD were similar in both groups of patients with both
acetate and bicarbonate dialysate. When the studies were repeated
under low-sodium dialysate conditions, several differences emerged
between acetate and bicarbonate HD. in group I, the frequency of ad-
verse symptoms upon standing after HD were reduced with bicarbo-
nate (P < 0.05). In group 2, bicarbonate HD prevented a significant
decrease in orthostatic MBP after HD. These results suggest that bi-
carbonate affords no greater hemodynamic stability than does acetate
if a dialysate sodium of 141 mEq/liter is used. With lower sodium di-
alysate, bicarbonate appears to provide a modest improvement in de-
creasing orthostatic symptoms and signs in patients with and without
autonomic insufficiency.
Hémodialyse a l'acétate et au bicarbonate chez des malades avec ou
sans dysfonctionnement autonome. Afin de tester Ia contribution
des bicarbonates (Bi) a Ia stabilité hémodynamique au cours de
l'hemodialyse (HD), nous avons compare les effets hemodynamiques
d'une dialyse avec ultrafiltration avec BiHD ou HD avec acetate (Ac)
pour des dialysats riches (141 mEq/Iitre) ou pauvres (130 mEqllitre) en
sodium chez 12 malades HD stables. Les malades du groupe 1 (N =
5) avaient une fonction autonome intacte, alors que ceux du groupe 2(N = 7) avaient des tests autonomes anormaux. Aucun des malades,
ni le personnel n'étaient au courant du dialysat utilisé. Pendant les
etudes avec un dialysat riche en sodium, les modifications de la pres-
sion artérielle moyenne (MBP), du debit cardiaque (CO) et de Ia
tolerance orthostatique a Ia station debout aprés HD étaient identiques
dans les deux groupes de malades, avec dialysat Ac ou Bi. Quand ces
etudes ont été répétées avec un dialysat pauvre en sodium, plusieurs
differences sont apparues entre Ac et BiHD. Chez les malades du
groupe 1, Ia frequence des symptômes indésirables a Ia station debout
après HD était réduite avec BiHD (P < 0,05). Chez les malades du
groupe 2, BiHD prévenait une diminution significative de MBP ortho-
statique apres HD. Ces rCsultats suggèrent que BiHD ne procure pas
une plus grande stabilité hemodynamique qu'AcHD si un sodium dans
le dialysat de 141 mEq/liter est employé. Avec un dialysat plus pauvre
en sodium, BiHD semble apporter une amelioration modeste en dimin-
uant les symptômes orthostatiques et les manifestations chez les
malades avec ou sans insuffisance autonome.
acceptable frequency of side effects. In part, the morbidity of
the procedure is due to the underlying diseases that patients
with end-stage renal disease typically possess. Among these,
the dominant ones are autonomic nervous system dysfunction
[1—51, cardiovascular and peripheral vascular disease, and
hypertension [6—7]. Any dialysis maneuver that enhances the
ability to remove volume by ultrafiltration without inducing
hypotension represents a significant improvement in dialytic
therapy. In this regard, it is important to note that by stabiliz-
ing plasma osmolality with a higher sodium dialysate concen-
tration (140 mEq/liter), the frequency of several adverse ef-
fects of dialysis are reduced [81.
Similarly, bicarbonate dialysate has been proposed to afford
dialysis patients a reduced morbidity during ultrafiltration, pre-
sumably by reducing peripheral vasodilation attributed to ac-
etate and avoiding any cardiodepressant effects acetate may
have on the myocardium [9—17]. This alledged advantage of bi-
carbonate dialysate, however, has not been universally ac-
cepted. In fact, several recent studies have been unable to
document any cardiodepressant effect of acetate in patients,
nor have they shown any clear-cut adverse effects on the pe-
ripheral vasculature [18—221. Several of the differences in con-
flicting studies may have arisen because of patient selection,
because the population of dialysis patients is in general so
heterogeneous from a medical standpoint.
Thus, in an effort to reconcile these differences on the he-
modynamic effects of acetate and bicarbonate dialysate, we
undertook the present studies. To delineate a more precisely
defined population of dialysis patients who might benefit from
bicarbonate dialysate, we prospectively tested the study pa-
tients to determine autonomic nervous system integrity. We
reasoned that patients with autonomic dysfunction might be
more stabilized with bicarbonate dialysate. In addition, we
evaluated both bicarbonate and acetate dialysate under two dif-
ferent dialysate sodium concentrations (141 mEq/liter and 130
mEq/liter) to clarify the conditions under which the buffers pro-
vided protection from morbidity. Also included in these inves-
tigations were measurements of cardiac output, orthostatic
Despite several major improvements in hemodialysis tech-
niques, the procedure continues to be accompanied by an Un-
59
Received for publication July 26, 1983
and in revised form November 28, 1983
© 1984 by the International Society of Nephrology
60 Velez et al
blood pressures after weight loss, and acid-base changes. The
results showed no improvement in hemodynamic stability by
bicarbonate dialysate when a dialysate sodium of 140 mEq/liter
was used. When the dialysate sodium was reduced to 130
mEq/liter, bicarbonate dialysate provided a significant mea-
sure of hemodynamic stability, particularly in patients with au-
tonomic dysfunction.
Methods
Patients. Twelve male chronic stable hemodialysis patients
volunteered for this study. The mean age was 56 4 years
(range, 34 to 65 years) and the mean duration of dialysis was
5.5 1.0 years (range, 1 to 14 years). None of the patients had
clinical evidence of congestive heart failure (by chest x-ray and
physical exam) at the time of the study. Three patients were
receiving antihypertensive medications, which were discontin-
ued for the duration of the study. The etiology of renal failure
was hypertensive nephrosclerosis (N = 4), chronic glomeru-
lonephritis (N = 3), polycystic kidneys (N = 2), analgesic
abuse (N = 1), chronic pyelonephritis with obstruction (N =
1), and milk alkali syndrome (N = 1). No patient had diabetes
mellitus as the cause of renal failure. All patients gave written
informed consent for the study, and the protocol was ap-
proved by the Institutional Review Boards of the Dallas
VAMC and Southwestern Medical School.
Autonomic tests. The study population was divided into two
groups based on the results of autonomic testing: Group 1 had
normal findings, group 2 had abnormal findings.
For part 1 of the study (high-sodium dialysate, see "Dialysis
protocol"), group 1 consisted of 5 patients and group 2 of 7 pa-
tients. In part 2 of the study (low-sodium dialysate), 4 patients
from group 1 and 4 patients from group 2 continued the study.
Thus, the number of patients differs in parts I and 2 of the
study.
Autonomic testing was accomplished by using three dif-
ferent maneuvers [1, 23, 24]:
(1) A standard Valsalva test was performed by forced expi-
ration of 40 mm Hg against a closed valve for 10 to 12 sec-
onds. An abnormal response was defined as the absence of an
arterial pressure overshoot and bradycardia after release of the
strain [24].
(2) The hand grip test was performed by sustained hand grip
at 30% of maximum voluntary contraction (MVC) for 3 min-
utes using a standard hand-grip dynamometer [23]. An ab-
normal response was defined as a <15-mm-Hg rise in diastolic
blood pressure.
(3) The amyl nitrate inhalation test was performed in a stand-
ard manner and blood pressure followed closely. Heart rate
(HR) was assessed from a continuous electrocardiographic
rhythm strip. An abnormal response was defined as a
HRILMBP ratio of <0.6 [1]. Each patient underwent auto-
nomic testing on two separate occasions before dialysis to
verify the consistancy of results. Patients with inconsistent au-
tonomic tests were not included in the study population. The
results of this series of autonomic tests are listed in Table 1.
Dialysis protocols. The study was divided into two sections:
Part 1 was performed with a high-dialysate sodium (141
mEq/liter) concentration, and part 2 was performed with a
lower dialysate sodium concentration (130 mEq/liter). The
composition of the dialysates is depicted in Table 2. The dial-
Table 1. Results of autonomic testinga
Group I(N=5) P Group 2(N=7)
Hand grip, zMBP, mm Hg 30.4 3.6 12.0 0.9
<0.001
Amyl nitrate, LHRIMBP 0.9 0.2 0.3 0.1
<0.001
Valsalva maneuver Normal Abnormal
a Group 1 represents patients with a normal response; group 2, those
with an abnormal response to autonomic testing. Values for the first
two measures are the means SEM.
Table 2. Dialysate compositions during the studya
Part 1 Part 2
Acetate Bicarbonate Acetate Bicarbonate
Sodium,
mEqiliter
Potassium,
mEqiliter
Chloride,
mEqiliter
Bicarbonate,
mEqiliter
Acetate,
mEqiliter
Glucose,
mgldl
140.4 1.0
2.6 0.1
112.8 1.3
—
37
255.9 2.4
141.5
2.6
111.8
35.7
261.1
0.7
0.1
0.6
0.6
—
3.0
129.4 2.3
2.3 0.1
102.6 1.9
—
35
209 1.2
130.5 2.3
2.3 0.2
102.4 1.4
32.6 0.3
—
212 1.7
a Values are the means SEM.
ysate composition was verified by laboratory analysis for each
use. Each patient was dialyzed once with bicarbonate and once
with acetate dialysate. The patients and staff were unaware of
the type of dialysate being used.
An identical protocol was followed during each dialysis ma-
neuver. Following insertion of needles for standard dialysis,
the patient remained recumbent for 15 minutes. The identical
dialyzer (1.0 m2) and delivery system (Travenol RSP, Tray-
enol Laboratories, Deerfield, IL) was used in each patient.
Blood samples were then obtained from the arterial line, and
cardiac output (CO) was measured by the green dye injection
technique as previously reported [25]. After rapid injection of
green dye via the venous dialysis needle, cardiac output was
computed by the dye dilution technique using a Lyons Cardiac
Output Computer (model DCCO-04; Lyons Medical Instru-
ment Corporation, Electronics for Medicine, Pleasantville,
NY). The duvette was attached to the arterial needle and to a
Harvard withdrawal pump (Harvard Instruments, Cambridge,
MA) for withdrawing the blood. Cardiac outputs were mea-
sured in duplicate in the supine position predialysis (time 0), at
1 hour of dialysis (time I), at 3 hours of dialysis (time 3), and 1
hour postdialysis (time 4). The time-3 measurement of cardiac
output was performed before the blood in the dialyzer was re-
turned to the patient. Dialysis was discontinued for 5 minutes
during each of the cardiac output measurements. Hemodi-
alysis was then commenced for a duration of 3 hours. After
dialysis, the identical procedure that preceded dialysis was re-
peated. Blood pressure and heart rate were recorded before
and after dialysis and at 30-minute intervals during dialysis;
mean blood pressure (MBP) was calculated from the diastolic
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Table 3. Changes in weight and blood composition before (Pre) and after (Post) dialysis in which the dialysate sodium was 141 mEq/litera
Acetate dialysis Bicarbonate dialysis
Pre P Post Pre P Post 5
Group I: Normal autonomic responses (N = 5)
Weight, kg 86.4 5.7 0.05 84.4 5.6 87.0 5.6 0.05 84.7 5.7 NS
Sodium, rnEq/liter 139.4 1.74 NS 139.8 1.2 137.8 1.42 NS 138.2 0.9 NS
Potassium, mEq/liter 4.6 0.5 0.05 3.8 0.3 4.6 0.4 0.05 3.8 0.2 NS
Chloride, mEqlliter 103.8 1.1 NS 106.4 1.8 102.6 1.8 NS 101.8 1.0 <0.05
Bicarbonate, mEqiliter 15.6 1.3 0.01 18.8 1.3 17.0 1.2 0.001 23.6 0.9 <0.001
Creatinine, mg/dl 21.1 1.6 0.001 14.7 0.8 20.6 0.9 0.001 13.9 0.9 NS
Osmolality, mosrnlkg 318.2 5.3 0.001 308.4 3.9 322.8 4.6
Group 2: Abnormal autonomic responses (N = 7)
0.001 309.4 5.2 NS
Weight, kg 75.3 4.4 0.001 73.1 4.5 75.5 4.5 0.001 73.7 4.4 NS
Sodium, mEq/liter 140.1 1.0 NS 141.7 1.9 141.4 1.2 NS 141.3 0.8 NS
Potassium, mEqiliter 5.1 0.1 0.005 4.4 0.1 5.2 0.1 0.005 4.3 0.1 NS
Chloride, mEq/liter 101.7 1.4 NS 103.3 2.9 106.3 2.2 0.001 103.6 1.0 NS
Bicarbonate, mEqiliter 18.9 0.8 0.05 19.8 1.2 17.4 1.6 0.001 23.4 1.3 <0.01
Creatinine, mg/dl 16.1 1.4 0.001 10.4 1.1 15.5 1.4 0.001 10.6 1.1 NS
Osmolality, mosm/kg 315.9 2.7 0.001 302.1 2.2 315.4 2.1 0.001 304.2 1.3 NS
a Values are the means SEM. Note: All predialysis values for acetate and bicarbonate are comparable.
Comparing postdialysis values (acetate vs. bicarbonate).
BP + 1/3 of the pulse pressure. Orthostatic blood pressures
were obtained after the cardiac outputs were performed predi-
alysis and postdialysis. Symptoms of nausea, vomiting, muscle
cramping, chest pain, diaphoresis, or seizures were designated
prospectively as significant and were recorded for statistical
analysis. Specific therapy for the symptoms was also re-
corded. Routine blood work analysis was performed in the
clinical laboratory. Plasma osmolality was measured by freez-
ing-point depression using an Advanced Instruments Osmome-
ter (Advanced Instruments, Inc., New Highland, MA).
Statistical analysis. Statistical analysis was performed using
a two-tailed Student's t test for paired data; where appropri-
ate, a two-way analysis of variance was used for multiple com-
parisons [26]. In the low-sodium studies, an unpaired t test was
used to compare the results of parts 1 and 2. All data are re-
ported as the means SEM. A P value of less than 0.05 was
considered significant.
Results
P < 0.01
Part 1: Dialysate sodium of 141 mEq/liter
(a) Changes in weight and blood components during dialy-
sis. Changes in weight and plasma electrolytes, creatinine, and
osmolality are provided in Table 3. Comparable and significant
decrements in weight and plasma potassium, creatinine, and
osmolality occurred in both groups of patients with either ac-
etate or bicarbonate HD. The bicarbonate concentration in-
creased significantly in both groups with both dialysates. Both
groups, however, had a significantly greater bicarbonate con-
centration after the bicarbonate procedure. The weight changes
in both procedures were comparable.
(b) Mean blood pressure changes. Mean blood pressure
(MBP) changes for the part-l studies are shown in Fig. 1. The
only significant difference between acetate and bicarbonate HD
was observed in group 2 (autonomic insufficiency group) at the
2-hour time of dialysis. At this time, the MBP was significantly
higher with acetate; however, MBP was comparable with both
dialysates at subsequent intervals.
(c) Cardiac output. Changes in cardiac output during he-
modialysis are shown in the upper portion of Table 4. Cardiac
output declined over the course of dialysis in both groups of
patients but no significant differences between acetate or bi-
carbonate HD were noted at any time interval.
(d) Orthostatic blood pressure testing and symptoms. Ortho-
static changes in MBP predialysis and postdialysis were deter-
mined to test the stability of the circulation after ultrafiltration
and weight loss, and the results are depicted in Fig. 2. As ex-
pected, supine MBP tended to be lower postdialysis, and or-
thostatic changes were more marked postdialysis. However,
no significant differences were noted in either group with ac-
etate or bicarbonate HD. As noted in Fig. 2, symptoms tended
to occur more frequently in patients with autonomic insuffi-
ciency when assuming upright posture.
Part 2: Dialysate sodium of 130 mEq/liter
In view of the comparable results in both groups of patients
with both dialysates, the identical procedures were repeated in
= 140 mEq/Iiter
Group 2
Dialysate sodium
Group 1
NS
110
E 100
90
CO
I
0 1 3 4 0 1 3 4
Time period Time period
Fig. 1. Supine mean blood pressure changes during acetate hemodi-
alysis (open circles) and bicarbonate hemodialysis (closed circles) in
patients with normal autanomic responses (group I) and in those with
abnormal autonomic responses (group 2). Time 4 represents 1 hour
postdialysis. P refers to acetate vs. bicarbonate.
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Table 4. Results of cardiac output during acetate and bicarbonate
hemodialysisa
Group 1
liters/mm
Group 2
liters/mm
Part 1 Studies: Dialysate sodium = 140 mEqlliter
Time 0
Acetate 7.9 1.0
Bicarbonate 8.8 0.6
Time 1
Acetate 7.6 0.8
Bicarbonate 8.7 0.7
Time 3
Acetate 7.0 0.7
Bicarbonate 6.8 0.6
Part 2 Studies: Dialysate sodium = 130 mEqiliter
Time 0
Acetate 7.5 0.8
Bicarbonate 8.1 0.9
Time 1
Acetate 5.8 0.4 6.8 1.2
Bicarbonate 6.1 1.1 6.5 0.6
Values are the means SEM. No significant differences were noted
between the acetate or bicarbonate procedures in either group with
either dialysate.
the two groups (4 patients per group) using a dialysate sodium
of 130 mEq/liter (Table 1).
(a) Weight and blood component changes. Comparable de-
creases in weight, plasma potassium, creatinine, and osmolal-
ity occurred with both acetate and bicarbonate RD (Table 5).
(b) Changes in cardiac output. Changes in cardiac output
during dialysis with both maneuvers are shown in the lower
portion of Table 4. Again, cardiac output decreased slightly
with both dialysates during dialysis. No significant differences
between acetate or bicarbonate HD were observed at any time.
(c) Changes in mean blood pressure. The supine mean blood
pressure changes during the course of the dialyses with the
lower sodium dialysate are depicted for both groups in Fig. 3.
No differences in MBP were noted at any time with acetate or
bicarbonate HD. Group 2 tended to have a lower supine MBP
when compared with group 2, but this did not reach statistical
significance.
(d) Orthostatic testing and symptoms. As shown in Fig. 4,
the use of the lower sodium dialysate was associated with strik-
ing orthostatic signs and symptoms after dialysis. Group 1 pa-
tients experienced a fall in MBP upon standing which did not
achieve statistical significance. After acetate HD, however, 3
out of 4 (75%) patients had adverse symptoms upon standing,
compared with only I in 4 patients after bicarbonate RD (P <
0.05). Thus, a tendency for bicarbonate HD to reduce ortho-
static symptoms was noted in group i.
After acetate HD and standing, group 2 patients (with ab-
normal responses to autonomic testing) had a sharp and sig-
nificant fall in MBP, and all of them became symptomatic. The
use of bicarbonate RD in this group of patients improved their
tolerance to weight loss modestly; the fall in MBP was not sig-
nificant and the incidence of symptoms was reduced to 50%.
The absolute upright MBP of these patients was 56 5 mm
Hg after acetate and 63 4 after bicarbonate HD (NS). The
absolute upright postdialysis MBP of group 2 was less than it
:r:
90 NS
40% Sx 35% Sx
Fig. 2. Orthosia tic mean blood pressure changes before (Pre) and af-
ter (Post) hemodialysis with acetate and bicarbonate. Group 1 repre-
sents patients with normal autonomic responses; and group 2, patients
with abnormal autonomic responses. Percent of patients becoming
symptomatic after dialysis when upright is depicted under the figures
(Sx). Solid bars (I) represent upright position; open bars (s), supine
position.
was for group 1 after both acetate (56 5 vs. 80 8 mm Hg,
P < 0.05) and bicarbonate RD (63 4 vs. 85 7 mm Hg, P
<0.05).
Discussion
Abnormalities of the autonornic nervous system are com-
mon in dialysis patients and may contribute to the frequent
hypotensive episodes encountered during dialysis. The dis-
order most typically affects the afferent autonomic pathway or
the baroreceptors themselves 3, 41 and potentially renders pa-
tients more vulnerable to hypotension during the rapid volume
removal that occurs during dialysis, In addition to the afferent
limb defects, some investigators have found reduced end-or-
gan response or a malfunction in the efferent pathway [5]. The
relationship of autonomic system dysfunction to hemodynamic
stability is therefore an important consideration when the ef-
ficacy and safety of dialysates are evaluated. The present se-
ries of studies were designed to examine the importance of
autonomic dysfunction in the context of two dialysate buffers
(acetate and bicarbonate) under conditions of varying sodium
concentrations (141 mEq/liter and 130 mEq/liter). Such an ex-
amination seemed pertinent in view of the current debate over
which dialysate is more beneficial, bicarbonate or acetate.
Dialysate sodium = 140 mEq/Iiter
Group 1
Bicarbonate
Post
110
8.2±0.8
8.3 0.7 100{0
a)
907.3±0.9 .
7.5±0.8 0E2 80
.0
7.3±0.9 707.7±0.8 '
60
8.9 1.1
8.1 0.6
7.8 1.4
7.5 1.2
Acetate
Bicarbonate
Time 3
6.2 0.5
6.6 0.6
Group 2
Acetate Bicarbonate
110
a)
100(0
90
2 80
.0
C
Ca 70
a)
60
Post
100% Sx 50% Sx
Fig. 4. Orthostatic mean blood pressure changes before (Pre) and af-
ter (Post) hemodialysis with acetate and bicarbonate in patients with
normal (group 1) and abnormal (group 2) autonomic responses. Per-
cent of patients becoming symptomatic (Sx) after dialysis when up-
right is depicted under the figures. Solid bars (U) represent upright po-
sition; open bars () supine position.
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Table 5. Changes in weight and blood composition before (Pre)and after (Post) dialysis in which the dialysate sodium was 130 mEq/litera
Acetate dialysis
Pre P Post Pre P Post
Bicarbonate dialysis
Group 1: Normal autonomic responses (N = 4)
Weight, kg 82.9 4.7 0.01 80.5 4.8 82.6 5.1 0.005 80.2 5.0 NS
Sodium, mEqiliter 139.0 1.8 NS 135.5 0.9 139.7 1.8 NS 134.7 3.0 NS
Potassium, mEqiliter 4.4 0.4 0.05 3.5 0.3 4.3 0.4 0.05 3.4 0.2 NS
Chloride, mEqiliter 100.5 1.5 NS 97.2 0.5 102.5 1.9 NS 96.2 2.2 NS
Bicarbonate, mEqiliter 16.2 0.8 0.05 20.7 0.9 17.5 1.4 0.05 22.2 1.0 NS
Creatinine, mg/dl 22.9 1.4 0.001 15.4 1.1 23.8 1.5 0.001 15.3 1.8 NS
Osmolality, mOsmlkg 320.2 5.1 0.001 301.2 3.11 310.7 5.2
Group 2: Abnormal autonomic responses (N = 4)
0.001 301.7 3.2 NS
Weight, kg 78.2 7.7 0.005 76.0 7.9 78.2 7.4 0.05 76.3 7.6 NS
Sodium, mEqlliter 140.0 2.8 NS 135.2 0.7 142.7 1.8 NS 137.0 1.1 NS
Potassium, mEqiliter 5.0 0.1 0.001 3.7 0.1 5.0 0.1 0.001 3.9 0.2 NS
Chloride, mEqiliter 101.2 1.7 NS 97.2 0.5 106.7 2.2 0.05 97.5 0.3 NS
Bicarbonate, mEqililer 16.9 1.3 0.005 20.4 0.6 17.5 1.3 0.001 22.0 0.7 NS
Creatinine, mgldl 15.2 1.5 0.001 9.3 1.0 15.3 0.9 0.001 9.4 0.9 NS
Osmolality, mOsmlkg 320.2 2.0 0.001 299.2 1.5 318.2 5.9 0.001 296 5.7 NS
a Values are the means SEM. Note: All predialysis values for acetate and bicarbonate are comparable.
b Comparing postdialysis values (acetate vs. bicarbonate).
Dialysate sodium = 130 mEq/Iiter Dialysate sodium = 130 mEq/Iiter
Group 1
Acetate Bicarbonate110
Group2
NS 111(0(0
100
______________
90
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CO
0)
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0)
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!
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Fig. 3. Supine mean blood pressure during acetate and bicarbonate he-
modialysis. Group I represents patients with normal autonomic re-
sponses, and group 2 represents those with abnormal responses. Time
4 represents 1 hour postdialysis.
The inclusion of acetate dialysate studies is particularly rel-
evant in view of the controversy regarding alledged cardiode-
pressant effects [14—16] and peripheral vasodilatory effects of
acetate 114, 15]; both of these effects would combine to further
compromise an effective protection of blood pressure during a
volume-lowering maneuver. Evidence that acetate may cause
peripheral vasodilation has been provided by Aizawa et al [15],
who found a significant increase in limb blood flow after ac-
etate hemodialysis and an unchanged mean arterial blood pres-
sure. These investigators also suggested that myocardial de-
pression was caused by acetate hemodialysis, as assessed by
the ratio of the preejection period to the left ventricular ejec-
tion time. Kirkendol et a! [141, using a hind-limb model, also
showed rapidly infused acetate to have weak vasodilator prop-
erties; this infusion also produced a decrease in myocardial
contractile force. In a later study, however, using slow infu-
sions of sodium acetate, myocardial depression did not occur
[221. It is of interest to note that studies using impedance car-
diography have evaluated cardiac performance in adult
hemodialysis patients and have shown that patients with doc-
umented hyperacetatemia were able to maintain an elevated
cardiac output, suggesting that acetate hemodialysis is not a
75% Sx 25% Sx
Acetate
Group 2
Bicarbonate
Pre Post
a)
(0(0a
OE0
.0
Caa
110
100
90
80
70
60
cardiodepressant. Similar conclusions regarding acetate were
reached by Liang and Lowenstein [27] after experiments with
slow acetate infusions in the dog.
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In the first series of experiments in the present studies (di-
alysate sodium of 141 mEq/liter), group I (normal autonomic
response to testing) and group 2 (abnormal autonomic re-
sponse) patients were observed to have similar hemodynamic
responses to the two dialysates. Specifically, MBP (Fig. 1),
cardiac output (Table 4), and, importantly, postdialysis ortho-
static blood pressure changes (Fig. 2) were comparable with ei-
ther dialysate buffer. Although group 2 patients had a some-
what higher incidence of symptoms upon standing compared
with group 1 patients (Fig. 2), the use of bicarbonate dialysate
did not significantly reduce the frequency of the symptoms.
The use of an orthostatic blood pressure challenge after dial-
ysis has been previously shown to be a useful and predictable
test of hemodynamic stability in dialysis studies of this type [81.
Thus, the use of bicarbonate dialysate afforded no benefit in ei-
ther group of patients under circumstances in which dialysate
sodium was 141 mEq/liter. It should be stressed that the pa-
tients selected for the study had consistent responses to the au-
tonomic tests and were divided prospectively. Further, these
patients and the dialysis staff were not aware of which buffer
was being used.
A different series of observations were made when the stud-
ies were repeated with the dialysate sodium reduced to 130
mEq/liter. Prior investigations have ascribed an important ben-
efit to the stability of plasma osmolality achieved by a higher
dialysate sodium concentration [8, 20, 21]. Thus, more hypo-
tension and symptoms would be expected to occur using the
lower sodium dialysate. In view of the negative findings with
the higher dialysate sodium, the rationale for the second series
of studies was to provide a dialysis setting in which bicarbo-
nate might be most likely to show some hemodynamic protec-
tive effects. The tests were again applied to patients with and
without autonomic insufficiency.
As shown in Fig. 3, neither dialysate was associated with
profound hypotension as long as the patients remained in the
recumbant position. Similarly, the decrements in cardiac out-
puts were also comparable for the two procedures for each
group of patients. But when orthostatic challenge was applied
postdiaiysis (Fig. 4), the use of bicarbonate dialysate appeared
to reduce symptoms and stabilize blood pressure in both
groups of patients. Whereas 75% of group I patients experi-
enced adverse symptoms upon standing after acetate dialysis,
only 25% of them had symptoms after bicarbonate dialysate.
Similarly, the fall in MBP upon standing after acetate dialysis
in group 2 was significant but did not reach statistical signifi-
cance after bicarbonate dialysis. Adverse symptoms were
somewhat less frequent in group 2 after standing and bicarbo-
nate dialysis as well. Thus, in the aggregate, bicarbonate di-
alysate appeared to reduce the frequency of adverse events
caused by standing in these low dialysate sodium studies. It
should be noted, however, that the number of patients is small
in these low-sodium dialysate studies, and the results must be
interpreted cautiously. Both groups 1 and 2, however, re-
ceived some modest benefit (either reduced symptoms or a less
precipitous decrease in MBP) when bicarbonate dialysate was
tested under low sodium conditions. Another feature of the re-
sults is that, with both dialysates, the postdialysis upright MBP
of group 2 was significantly less than it was for group 1.
The precise mechanism of this benefit is unknown. Cardiac
outputs were not performed in the upright position because the
majority of patients became symptomatic and had to resume
recumbancy before a reliable cardiac output could be mea-
sured. It is therefore possible that either a stabilization of pe-
ripheral vascular tone or improvement in cardiac performance
contributed to the hemodynamic stability. The latter possibil-
ity seems the least likely in view of the comparable cardiac out-
puts observed with acetate and bicarbonate throughout the
course of the study (Table 4).
These results provide several insights into the causes of
hypotension on dialysis. First, the differences in the incidence
and severity of hypotensive signs and symptoms between the
dialysate sodiums of 141 and 130 mEq/liter are striking. The re-
suits clearly emphasize the importance of a stable plasma
osmolality in protecting blood pressure, presumably by stabi-
lizing plasma volume during the dialysis procedure [8, 20, 21].
Second, the results do not provide evidence for a depressant
cardiac effect of acetate, an observation with growing support
in the recent literature [18]. Third, the results do suggest that
bicarbonate dialysate is helpful in reducing adverse hypoten-
sive symptoms and signs in the context of a low-sodium dialy-
sate in both autonomically sufficient and insufficient patients.
These protective features of bicarbonate dialysate were mod-
est in this study, possibly a feature related to the lower number
of patients in the low-sodium protocols. Finally, when chal-
lenged with upright posture after low-sodium dialysis, the pa-
tients with the abnormal autonomic responses were shown to
be at greater risk to hypotension than were the patients with
the normal autonomic responses. Thus, the use of a lower so-
dium dialysate uncovered differences in hemodynamic stabil-
ity that were more marked in the setting of autonomic insuffi-
ciency but reduced with bicarbonate dialysate.
It should be acknowledged that the patients selected for this
study had normal baseline cardiac outputs. Thus, it is conceiv-
able that patients with a baseline reduction in cardiac output
may demonstrate a differential response to bicarbonate and ac-
etate even at the higher dialysate sodium concentration. Fur-
ther, it is also possible that acetate and bicarbonate may have
differing effects on contractility in patients with depressed car-
diac function predialysis.
Summary. Under conditions in which a dialysate sodium of
141 mEq/liter is used, bicarbonate offers no apparent hemody-
namic advantage over acetate in stable dialysis patients. A
slightly higher postdialysis bicarbonate does result from use of
bicarbonate dialysate, which may have relevance in retarding
the advance of renal osteodystrophy. Under circumstances in
which dialysate sodium is 130 mEq/liter, bicarbonate dialysate
appears to improve orthostatic tolerance after dialysis. Thus,
in patients who are able to be dialyzed with a 141-mEq/liter di-
alysate, acetate dialysate offers no hemodynamic disadvan-
tage. In patients who are unable to tolerate higher sodium di-
alysates because of thirst, hypertension or heart failure, the use
of bicarbonate dialysate would be expected to reduce adverse
symptoms and signs. The exact mechanism of the improved
bicarbonate effect under these circumstances is not provided
by the present results. Finally, the prospective testing of the
autonomic nervous system is a useful predictor of patient
stability, particularly if the use of a low-sodium dialysate is
necessary.
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